| Patents for A61P 13 - Drugs for disorders of the urinary system (56,135) |
|---|
| 06/16/2009 | US7547693 Piperidine derivative |
| 06/16/2009 | US7547680 Benzimidazole derivatives and medical uses thereof |
| 06/16/2009 | CA2381097C Arylmethyl-carbonylamino-thiazole derivatives and their use as antitumor agents |
| 06/11/2009 | WO2009072649A1 4-arylphenyl derivative |
| 06/11/2009 | WO2009071947A2 Potassium ion channel modulators and uses thereof |
| 06/11/2009 | WO2009071033A1 Method for improving the stability and bioavailability of lipid extract of cucurbita pepo l. seeds and resulting composition |
| 06/11/2009 | WO2009070818A1 Pharmaceutical preparation for treating benign prostatic hyperplasia |
| 06/11/2009 | WO2009044006A3 5-(4-chlorophenyl)-1-(2,4-dichlorophenyl)-4-methylpyrazole-3-carboxylic acid the pharmaceutically-acceptable esters and salts and solvates thereof for use as medicament |
| 06/11/2009 | US20090149476 3-[[6-[4-(1,2,3,4-tetrahydro-1,8-naphthyridin-7-yl)-1-piperidinyl]-2,5-dimethyl-4-pyrimidinyl]amino]-N-[(phenylmethoxy)carbonyl]alanine, used for the treatment of osteoporosis, restenosis, arteriosclerosis, nephropathy or retinopathy |
| 06/11/2009 | US20090149445 Tricyclic steroid hormone nuclear receptor modulators |
| 06/11/2009 | US20090149378 Glp-1 analogues |
| 06/11/2009 | US20090149373 Use of survivin to treat kidney failure |
| 06/11/2009 | US20090148536 plant extracts, herbs; pulverization |
| 06/11/2009 | US20090148446 Method and Composition for Treatment of Renal Failure with Antibodies and Their Equivalents as Partial or Complete Replacement for Dialysis |
| 06/11/2009 | CA2705986A1 Pharmaceutical preparation for treating benign prostatic hyperplasia |
| 06/10/2009 | EP2067863A2 Methods and compositions for diseases associated with amyloidosis |
| 06/10/2009 | EP2067488A1 Albumin fusion proteins |
| 06/10/2009 | EP2066311A2 Second line treatment of metastatic hormone refractory prostate cancer using satraplatin |
| 06/10/2009 | EP1319003B1 Xanthine phosphodiesterase v inhibitors |
| 06/10/2009 | CN101450934A Sulfonyl-derivatives as novel inhibitors of histone deacetylase |
| 06/10/2009 | CN100497598C Gynogenetic or androgenetic production of pluripotent cells and cell lines, and use thereof to produce differentiated cells and tissues |
| 06/10/2009 | CN100497577C Kidney tonic hygienic wine and its preparation |
| 06/10/2009 | CN100497388C Antibody selective for tumor necrosis factor-related apoptosis-inducing ligand receptor and use thereof |
| 06/10/2009 | CN100497340C Condensed purine derivatives as A1 adenosine receptor antagonists |
| 06/10/2009 | CN100497323C New heterocyclic oxime compounds, preparing process and medical composition thereof |
| 06/10/2009 | CN100497314C Substituted 4-phenyltetrahydroisoquinolinium, process for their preparation, their use as a medicament, and medicament containing them |
| 06/10/2009 | CN100497302C Diarylurea derivatives and their use as chloride channel blockers |
| 06/10/2009 | CN100496568C Jin-Gui-Shen-Qi capsule preparation method |
| 06/10/2009 | CN100496485C Antineoplastic combinations |
| 06/10/2009 | CN100496298C Process for producing liquid formulation containing raw yeast and liquid formulation |
| 06/09/2009 | US7544716 N-(7-hydroxy-5,6,7,8-tetrahydronaphthalen-1-yl)-N'-[3-piperidin-1-yl-4-(trifluoromethyl)benzyl]urea; urinary incontinence, overactive bladder, pain, nerve injury, ischemia, neurodegeneration, stroke, inflammatory disorders, asthma and chronic obstructive pulmonary disease |
| 06/09/2009 | US7544711 Cyclooxygenase inhibitors; musculoskeletal and cardiovascular disorders; antiinflammatory agents |
| 06/09/2009 | US7544708 To treat diseases of respiratory, urinary and gastrointestinal systems; highly selective; significant potency; (2R,2S)(1 alpha ,5 alpha ,6 alpha )-N-{-[4-(1,3-dioxo-1,3-dihydro-isoindol-2-yl)-butyl]-3-azabicyclo[3.1.0]hex-6-yl-methyl}-2-hydroxy-2-cyclopentyl-2-phenylacetamide |
| 06/09/2009 | US7544700 4-chloro-N-((5-((4-(hexylamino)piperidin-1-yl)sulfonyl)thien-2 -yl)methyl)benzamide for example; JUN kinase inhibitors to treat nervous system disorders, cancer, cardiovascular and autoimmune disorders |
| 06/09/2009 | US7544359 Antiischemic agents; anticholesterol agents; cardiovascular disorders |
| 06/09/2009 | CA2401812C Use of pdgf receptor tyrosine kinase inhibitors for the treatment of diabetic nephropathy |
| 06/09/2009 | CA2388939C Therapeutic treatments for blood cell deficiencies |
| 06/04/2009 | WO2009069993A1 Pharmaceutical composition combining various antispasmodic agents and a non-steroidal anti-inflammatory agent, which can be used to control and treat renal colic and inflammation |
| 06/04/2009 | WO2009069736A1 Nitrogenated compound |
| 06/04/2009 | US20090143463 Therapeutic Agent and Treatment Method for Ameliorating Uremia |
| 06/04/2009 | US20090143412 Furopyridine and furopyrimidine derivatives for the treatment of hyper-proliferative disorders |
| 06/04/2009 | US20090143402 Isoquinolinone derivatives as nk3 antagonists |
| 06/04/2009 | US20090143386 Human adam-10 inhibitors |
| 06/04/2009 | US20090143319 Transcription factor decoy |
| 06/04/2009 | US20090142831 Placental stem cells |
| 06/04/2009 | US20090142782 Using actinobacillus specific immunogolbulins to diagnose gum disease |
| 06/04/2009 | CA2853152A1 Compositions and methods for treating vaginal infections and pathogenic vaginal biofilms |
| 06/03/2009 | EP2065401A2 An antibody selective for a tumor necrosis factor-related apoptosis-inducing ligand receptor and uses thereof |
| 06/03/2009 | EP2065400A2 An antibody selective for a tumor necrosis factor-related apoptosis-inducing ligand receptor and uses thereof |
| 06/03/2009 | EP2065384A1 Tricyclic thrombin receptor antagonist |
| 06/03/2009 | EP2065369A1 Urea compound or salt thereof |
| 06/03/2009 | EP2065053A1 Cell death inhibitor |
| 06/03/2009 | EP2065052A2 Anti-IgE vaccines |
| 06/03/2009 | EP2064252A2 Process for the preparation of sevelamer hydrochloride and formulation thereof |
| 06/03/2009 | EP1682546B1 Peptidomimetic compounds, stereoselective process for their preparation, their use as biologically active synthetic intermediates |
| 06/03/2009 | EP1313737B1 Novel guanidino derivatives as inhibitors of cell adhesion |
| 06/03/2009 | CN101445504A Dioxane-2-alkyl carbamates derivatives |
| 06/03/2009 | CN101444496A Compounds for the treatment of metabolic disorders |
| 06/03/2009 | CN101444476A New microsphere and method for producing the same |
| 06/03/2009 | CN100493545C Process for preparing kidney-tonifying wolfberry fruit capsule |
| 06/02/2009 | US7541378 tert-butyl 3-amino-1H-thieno[2,3-c]pyrazole-5-carboxylate; N-benzyl-3-[(4-fluorobenzoyl)amino]-1H-thieno[2,3-c]pyrazole-5-carboxamide; treats a disease caused associated with an altered (disregulated) protein kinase activity e.g cancer, cell proliferative disorders, Alzheimer's disease, viral infections |
| 06/02/2009 | US7541375 Azole derivatives and pharmaceutical compositions containing them |
| 06/02/2009 | US7541369 Amino-derivatives as novel inhibitors of histone deacetylase |
| 06/02/2009 | US7541362 7-(3,4-Dichlorophenyl)-4,7-dihydro-5-methyl-6-(5-phenyl-2-oxazolyl)pyrazolo[1, 5-a]pyrimidine |
| 06/02/2009 | US7541354 Bicyclo-pyrazoles |
| 06/02/2009 | US7541031 Methods for treating rheumatoid arthritis using human antibodies that bind human TNFα |
| 06/02/2009 | US7541024 A stable polyallylamine hydrochloride polymer crosslinked by epichlorohydrin |
| 06/02/2009 | US7541018 Treatment process using somatostatin analogues |
| 06/02/2009 | CA2464917C Racemic tamsulosin free base and methods of making the same |
| 06/02/2009 | CA2344290C Quinazoline derivatives |
| 06/02/2009 | CA2226548C Lyophilized hepatocyte growth factor preparations |
| 05/28/2009 | WO2009067410A1 Small-molecule modulators of trp-p8 activity |
| 05/28/2009 | WO2009066775A1 Amorphous form of heterocyclic compound, solid dispersion and medicinal preparation each comprising the same, and process for production of the same |
| 05/28/2009 | WO2009040671A4 Novel therapeutic uses of adrenergic alpha-1 receptor antagonists |
| 05/28/2009 | WO2009026517A3 Therapy for complications of diabetes |
| 05/28/2009 | WO2008051980A8 Methods of reducing phosphate absorption |
| 05/28/2009 | WO2008051977A8 Methods of reducing phosphate absorption |
| 05/28/2009 | US20090137845 Novel 4-Dedimethylaminotetracycline derivatives |
| 05/28/2009 | US20090137630 trans-R,R-2-chlorine-3N-(3a,4,5,6,7,7a-hexahydro-1H-2-benzimidazolyl)-4-methyl-3-thienylamine, having inhibitory properties on transport proteins, useful for treating respiratory system and nervous system disorders, ischemia, reperfusion injuries, fibrosis, diabetes, blood coagulation and infections |
| 05/28/2009 | US20090137604 corticotropin releasing factor receptor antagonists such as 8-(N-butyl-N-(2-butynyl)amino)-2-methyl-3-(2-chloro-4-methoxyphenyl)-6,7-dihydro-5H-cyclopenta[d]pyrazolo[1,5-a]pyrimidine, used for the treatment of nervous system, psychological, eating, sleep, and gastrointestinal disorders |
| 05/28/2009 | US20090137581 Heterocyclic compounds and their uses |
| 05/28/2009 | US20090137513 RNA Interference Mediated Inhibition of Acetyl-CoA-Carboxylase Gene Expression Using Short Interfering Nucleic Acid (siNA) |
| 05/28/2009 | US20090137512 nucleotide sequence complementary to a target RNA sequence and a second sequence chemically modified so it can no longer act as a guide sequence for mediating RNA interference, having complementarity to said first sequence; cancer, proliferative diseases |
| 05/28/2009 | US20090137511 RNA INTERFERENCE MEDIATED INHIBITION OF PLACENTAL GROWTH FACTOR GENE EXPRESSION USING SHORT INTERFERING NUCLEIC ACID (siNA) |
| 05/28/2009 | US20090137509 RNA INTERFERENCE MEDIATED INHIBITION OF PROLIFERATION CELL NUCLEAR ANTIGEN (PCNA) GENE EXPRESSION USING SHORT INTERFERING NUCLEIC ACID (siNA) |
| 05/28/2009 | US20090137508 Treatment of any disease that responds to modulation of gene expression, for example cancer, proliferative, inflammatory, metabolic, autoimmune, neurologic, ocular diseases; in vivo stability and bioavailability |
| 05/28/2009 | US20090137040 Methods for making and using reprogrammed human somatic cell nuclei and autologous and isogenic human stem cells |
| 05/28/2009 | CA2706536A1 Amorphous body composed of heterocyclic compound, solid dispersion and pharmaceutical preparation each comprising the same, and process for production of the same |
| 05/28/2009 | CA2706102A1 Small-molecule modulators of trp-p8 activity |
| 05/27/2009 | EP2062890A1 Tricyclic thrombin receptor antagonist |
| 05/27/2009 | EP2062884A1 Novel phenylacetic acid derivative |
| 05/27/2009 | EP2062879A1 Heterocyclic inhibitors of p38 |
| 05/27/2009 | EP2061470A2 Haloalkyl-substituted pyrimidinone derivatives |
| 05/27/2009 | EP2061450A2 Methods of modulating cell proliferation and cyst formation in polycystic kidney and liver diseases |
| 05/27/2009 | EP1589958B1 Reduced dose of tolterodine for treating urinary disorders |
| 05/27/2009 | EP1519915B1 Tricyclic steroid hormone nuclear receptor modulators |
| 05/27/2009 | EP1351672B1 Fatty acid analogues for the treatment of inflammatory and autoimmune disorders |
| 05/27/2009 | EP1292678B1 G-protein coupled receptors |
| 05/27/2009 | EP1171424B1 Cyclo-alkyl substituted benzimidazoles and their use as parp inhibitors |
| 05/27/2009 | CN101443340A Peptidomimetic inhibitors of psma, compounds comprising them, and methods of use |